By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Several times a year, a Confident Investor must reevaluate the companies in the portfolio. Keeping your money in a stock that no longer qualifies as a “Good” company can end up hurting your investment performance a great deal.  Also, there are a lot of Good Companies so losing the worst of the best is not going to impact the ability to have a balanced portfolio.  Over the coming days, this site will evaluate each stock on the Watch List.

 

Company name NRG Energy, Inc.
Stock ticker NRG
Live stock price [stckqut]NRG[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Fair
EPS growth Poor
P/E growth Good
EBIT growth Poor
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $28.18
Target stock price (averages with growth) $26.79
Target stock price (averages with no growth) $21.08
Target stock price (manual assumptions) $24.16

The following company description is from Google Finance: http://www.google.com/finance?q=nrg
NRG Energy, Inc. (NRG) is a wholesale power generation company. It is engaged in the ownership, development, construction and operation of power generation facilities, the transacting in and trading of fuel and transportation services, the trading of energy, capacity and related products in the United States and select international markets, and the supply of electricity and energy services to retail electricity customers in the Texas market. On May 1, 2009, the Company completed the acquisition of Reliant Energy, Inc. (Reliant Energy). On November 20, 2009, NRG, through its subsidiary NRG Solar LLC, acquired FSE Blythe 1, LLC (Blythe Solar) from First Solar, Inc. On November 9, 2009, NRG, through its wholly owned subsidiary, NRG Bluewater Holdings LLC, completed the acquisition of a 100% interest in the subsidiaries of Bluewater Wind LLC. In December 2009, NRG completed its Langford project, a 150 megawatt wind farm located in Tom Green, Irion, and Schleicher Counties, Texas.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns. This company used to be on the Watch List but I am removing it now that it dropped to Fair.

 

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Several times a year, a Confident Investor must reevaluate the companies in the portfolio. Keeping your money in a stock that no longer qualifies as a “Good” company can end up hurting your investment performance a great deal.  Also, there are a lot of Good Companies so losing the worst of the best is not going to impact the ability to have a balanced portfolio.  Over the coming days, this site will evaluate each stock on the Watch List.

 

Company name HealthStream, Inc.
Stock ticker HSTM
Live stock price [stckqut]HSTM[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Poor
Sales growth Good
EPS growth Poor
P/E growth Good
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $11.61
Target stock price (averages with growth) $14.11
Target stock price (averages with no growth) $7.94
Target stock price (manual assumptions) $11.4

The following company description is from Google Finance: http://www.google.com/finance?q=hstm
HealthStream, Inc. (HealthStream) provides Internet-based learning and research solutions to meet the training, information, and education needs of the healthcare industry. The Company?s learning products are used by healthcare organizations to meet a range of their training and assessment needs, while its research products provide its customers information about patients? experiences, workforce challenges, physician relations, and community perceptions of their services. HealthStream’s customers include healthcare organizations, pharmaceutical and medical device companies, and other participants in the healthcare industry. Its customer base across both learning and research business units includes over 2,500 healthcare organizations (predominately acute-care facilities) throughout the United States. It delivers educational and training courseware to its customers through the HLC platform.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns. Since the company is no longer ranked as Good, I will remove it from my Watch List.  If you have already built up a position in this stock, you may want to hold this stock and not aggressively add to your position.

 

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Several times a year, a Confident Investor must reevaluate the companies in the portfolio. Keeping your money in a stock that no longer qualifies as a “Good” company can end up hurting your investment performance a great deal.  Also, there are a lot of Good Companies so losing the worst of the best is not going to impact the ability to have a balanced portfolio.  Over the coming days, this site will evaluate each stock on the Watch List.

Company name F5 Networks, Inc.
Stock ticker FFIV
Live stock price [stckqut]FFIV[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Fair
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $168.44
Target stock price (averages with growth) $234.93
Target stock price (averages with no growth) $150.18
Target stock price (manual assumptions) $165.8

The following company description is from Google Finance: http://www.google.com/finance?q=ffiv
F5 Networks, Inc. (F5 Networks) is a provider of technology that optimizes the delivery of network-based applications and the security, performance and availability of servers, data storage devices and other network resources. Its technology is hardware and software for application delivery networking, including application security, secure remote access, policy management, wide area network (WAN) optimization and file virtualization. Its principal products are systems that integrate its software with purpose-built hardware that incorporates commodity components. In addition, it introduced a virtual (software only) version of BIG-IP called BIG-IP LTM (VE) that is designed to run on servers and work in conjunction with its systems to provide management of virtual servers and applications. Its BIG-IP product family, which represents the bulk of its sales, supports a growing number of features and functions available as software modules, standalone appliances, or both.

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Several times a year, a Confident Investor must reevaluate the companies in the portfolio. Keeping your money in a stock that no longer qualifies as a “Good” company can end up hurting your investment performance a great deal.  Also, there are a lot of Good Companies so losing the worst of the best is not going to impact the ability to have a balanced portfolio.  Over the coming days, this site will evaluate each stock on the Watch List.

Company name DeVry Inc.
Stock ticker DV
Live stock price [stckqut]DV[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $79.83
Target stock price (averages with growth) $125.43
Target stock price (averages with no growth) $114.7
Target stock price (manual assumptions) $65.79

The following company description is from Google Finance: http://www.google.com/finance?q=dv
DeVry Inc. (DeVry) is a provider of educational services and the parent organization of Advanced Academics, Becker Professional Education, Carrington College and Carrington College California, Chamberlain College of Nursing, DeVry Brasil, DeVry University, and Ross University. These institutions offer a range of programs in business, healthcare and technology and serve students in middle school through postsecondary education, as well as accounting and finance professionals. DeVry University provides bachelor?s and master?s degree programs in technology; science, business and the arts. DeVry University is a private, degree-granting, regionally accredited, higher education systems in North America. Ross University is a provider of medical and veterinary medical education. Chamberlain College of Nursing offers associate, bachelor?s, master?s and degree completion programs in nursing at its seven campuses in the United States and online.

Confident Investor comments: This is the first company in this Watch List refresh series that has stopped being a Good Company. At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns. If you already have built up an investment in this company, you may want to consider holding it and not add anymore.

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments
Company name Medco Health Solutions Inc.
Stock ticker MHS
Live stock price [stckqut]MHS[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Fair
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $67.03
Target stock price (averages with growth) $90.46
Target stock price (averages with no growth) $75.84
Target stock price (manual assumptions) $78.42

The following company description is from Google Finance: http://www.google.com/finance?q=mhs
Medco Health Solutions, Inc. (Medco) is a healthcare company. It provides clinically-driven pharmacy services designed to improve the quality of care and lower total healthcare costs for private and public employers, health plans, labor unions and government agencies of all sizes, and for individuals served by Medicare Part D Prescription Drug Plans. During the fiscal year ended December 26, 2009 (fiscal 2009), the Company administered 695 million prescriptions. In January 2010, the Company completed the acquisition of DNA Direct Inc. In April 2008, Medco acquired a majority interest in Europa Apotheek Venlo B.V. (Europa Apotheek), which provides mail-order pharmacy services in Germany. In 2009, Medco formed a joint venture with United Drug plc, a pan-European healthcare provider, to provide home-based pharmacy care services in the United Kingdom for patients covered by the country’s National Health Service.


Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.